Description
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Product Unit Size | Cost | Quantity | Stock |
|---|
fMLFK is a peptide that binds n-formyl peptide receptors (FPRs) on neutrophils, playing a role in neutrophil activation.
| Cas No. | 104180-18-9 |
|---|---|
| Purity | ≥95% |
| Formula | C27H43N3O5S |
| Formula Wt. | 565.74 |
| Synonym | Chemotactic peptide, N-Formyl-Met-Leu-Phe-Lys |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
He HQ, Troksa EL, Caltabiano G, et al. Structural determinants for the interaction of formyl Peptide receptor 2 with Peptide ligands. J Biol Chem. 2014 Jan 24;289(4):2295-306. PMID: 24285541.
mTOR inhibitor.
Non-competitive inhibitor of xanthine oxidase.<...
Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...
Diterpene vitamin A; RAR/RXR agonist.
ACE inhibitor.
Caffeic acid derivative.
Diterpene cafestol derivative found in coffee b...
Semi-synthetic analog of taxol; microtubule dep...
CRTH2 inhibitor.
ACE inhibitor.
Unlikely to reverse Alzheimer’s
Steroidogenesis inhibitor
Viral M2 proton channel blocker, MAO-A, NET, NM...
Indole alkaloid found in Evodia rutaecarpa; top...
CysLT1 antagonist.
KRAS inhibitor
Smoothened agonist.
Triadimefon metabolite; mutagen.
Mixture of oligomycins A, B, C; oxidative phosp...